The teriparatide in the treatment of severe senile osteoporosis

Archives of Gerontology and Geriatrics

Volumn 44, Issue SUPPL., 2007, Pages 249-258

  Manuele, S ^a   Sorbello, L ^a   Puglisi, N ^a   Grasso, S ^a   La Malfa, L ^a   D'Urbino, G ^a   Rizzotto, M ^a   Strano, S ^a   Maugeri, D ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Quality of life (QoL); Senile severe osteoporosis; Teriparatide treatment

Indexed keywords

ALENDRONIC ACID; CALCIUM; COLECALCIFEROL; NONSTEROID ANTIINFLAMMATORY AGENT; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID;

AGED; AGING; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FRACTURE; HUMAN; LUMBAR SPINE; OSTEOPOROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SENILE OSTEOPOROSIS; TREATMENT OUTCOME; VERTEBRA BODY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; OSTEOPOROSIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TERIPARATIDE;

EID: 33847020806     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2007.01.034     Document Type: Article

References (15)

1. Cummings S.R., and Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359 (2002) 1761-1767
2. Eriksen E.F., and Glerup H. Vitamin D deficiency and aging: implications for general health and osteoporosis. Biogerontology 3 (2002) 73-77
3. Gass M., and Dawson-Hughes B. Preventing osteoporosis-related fractures: an overview. Am. J. Med. 119 Suppl. 1 (2006) S3-S11
4. Genant H.K., Halse J., Briney W.G., Xie L., Glass E.V., and Krege J.H. The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis. Curr. Med. Res. Opin. 21 (2005) 1027-1034
5. Jiang Y., Zhao J.J., Mitlak B.H., Wang O., Genant H.K., and Ertiksen E.F. Recombinant human parathyroid hormone (1-34) (teriparatide) improves both cortical and cancellous bone structure. J. Bone Min. Res. 18 (2003) 1932-1941
6. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., and Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest. 104 (1999) 439-446
7. Khan A.W., and Khan A. Anabolic agents: a new chapter in the management of osteoporosis. J. Obstet. Gynaecol. Can. 28 (2006) 136-141
8. Kulenovic I., Rasic S., and Kulenovic E. Osteoporosis: current trends in diagnosis and management. Bosn. J. Basic Med. Sci. 6 (2006) 24-28
9. Lems W.F., Hamdy N.A., and Netelenbos J.C. Teriparatide: an anabolic drug for the treatment of patients with osteoporosis. Ned. Tijdschr. Geneeskd. 150 (2006) 132-137. (in Dutch)
10. Lin J.T., and Lane J.M. Osteoporosis: a review. Clin. Orthop. Relat. Res. 425 (2004) 126-134
11. Ma Y.L., Cain R.L., Halladay D.L., Yang X., Zeng Q., Miles R.R.., Chandrasekhar S., Martin T.J., and Onvia J.E. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteo-protegrin and gene-associated bone formation. Endocrinology 142 (2001) 4047-4054
12. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., Hodsman A.B., Eriksen E.F., Ish-Shalom S., Genant H.K., Wang O., and Mitlak B.H. Effect of parathyroid hormone on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344 (2001) 1434-1441
13. Reeve J., Hesp R., Williams D., Hulme P., Klenerman L., Zanelli J.M., Darby A.J., Tregear G.W., and Parsons J.A. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet 1 (1976) 1035-1038
14. Slovik D.M., Adams J.S., Neer R.M., Holick M.F., and Potts Jr. J.T. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N. Engl. J. Med. 305 (1981) 372-374
15. Zanchetta J.R., Bogado C.E., Ferretti J.L., Wang O., Wilson M.G., Sato M., Gaich G.A., Dalsky G.P., and Myers S.L. Effects of teriparatide (recombinant human parathyroid hormone: 1-34) on cortical bone in postmenopausal women with osteoporosis. J. Bone Min. Res. 18 (2003) 539-543